Related Experiment Video

Updated: Apr 28, 2026

Preparation Of Neovascular Tissues from Human Glioma Tissues for Quantitative Proteomics Analysis of Tumor Angiogenesis
09:21

Preparation Of Neovascular Tissues from Human Glioma Tissues for Quantitative Proteomics Analysis of Tumor Angiogenesis

Published on: March 20, 2026

119

Growth factor transduction pathways: paradigm of anti-neoplastic targeted therapy

Francesca Carlomagno1, Mario Chiariello

  • 1Dipartimento di Medicina Molecolare e Biotecnologie Mediche, Università degli Studi di Napoli Federico II, via Pansini 5, 80131, Naples, Italy, persfra@tin.it.

Journal of Molecular Medicine (Berlin, Germany)
|June 8, 2014
PubMed

Insights

Targeted cancer therapies, particularly for melanoma, are advancing by blocking the RTK/RAS/MAPK pathway. This research explores new drugs and resistance mechanisms in targeted cancer treatment.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • The RTK/RAS/MAPK pathway is frequently deregulated in human cancers, driving tumor growth.
  • Cancer cells often depend on this signaling pathway, making it a target for therapy.
  • Refractory melanoma cases highlighted the need for novel therapeutic strategies targeting this cascade.

Purpose of the Study:

  • To identify and clinically test new therapeutic approaches for blocking the RTK/RAS/MAPK cascade in melanoma.
  • To understand the molecular basis of resistance to targeted therapies in melanoma.

Main Methods:

  • Systematic analysis of cancer genomes.
  • Development of highly selective tumor-targeted drugs.
  • Clinical testing of new therapeutic agents.

Main Results:

  • Identification of new drugs for melanoma treatment.
  • Enhanced understanding of the molecular mechanisms underlying primary and secondary resistance to targeted therapies.

Conclusions:

  • Molecularly targeted therapies offer a promising avenue for cancer treatment, especially in melanoma.
  • Continued research into pathway deregulation and resistance mechanisms is crucial for advancing targeted cancer therapies.

More Related Videos

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells06:54

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Published on: October 27, 2020

13.1K
Mimicking the Function of Signaling Proteins: Toward Artificial Signal Transduction Therapy12:24

Mimicking the Function of Signaling Proteins: Toward Artificial Signal Transduction Therapy

Published on: September 29, 2016

6.4K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.0K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

1.4K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
4.7K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.5K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.3K